Barry M. Salzman's most recent trade in Checkpoint Therapeutics Inc was a trade of 17,638 COMMON STOCK done . Disclosure was reported to the exchange on Dec. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 17,638 | 134,812 (0%) | 0% | 0 | COMMON STOCK | |
Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 50,000 | 117,174 (0%) | 0% | 0 | COMMON STOCK | |
Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 32,051 | 67,174 (0%) | 0% | 0 | COMMON STOCK | |
Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,483 | 35,123 (0%) | 0% | 0 | COMMON STOCK | |
Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 24,390 | 112,280 (0%) | 0% | 0 | COMMON STOCK |